Related Experiment Video
Updated: May 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The Role of TGF-β Receptors in Fibrosis
Sashidhar Nakerakanti1, Maria Trojanowska
1Arthritis Center, Boston University School of Medicine, 72 East Concord St, Boston, MA 02118, USA.
Abstract:
Recent advances in defining TGF-β signaling pathways have provided a new level of understanding of the role of this pleiotropic growth factor in the development of fibrosis. Here, we review selected topics related to the profibrotic role of TGF-β . We will discuss new insights into the mechanisms of ligand activation and the contribution of Erk1/2 MAPK, PI3K/FAK, and Endoglin/Smad1 signaling pathways to the process of fibrosis. There is growing evidence of the disease-specific alterations of the downstream components of the TGF-β signaling pathway that may be explored for the future therapeutic interventions.
Insights
Transforming growth factor-beta (TGF-β) signaling is crucial in fibrosis development. New insights into its pathways, including Erk1/2 MAPK and PI3K/FAK, offer potential therapeutic targets for fibrotic diseases.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator in cellular processes.
- Fibrosis, a pathological hallmark of many diseases, involves excessive extracellular matrix deposition.
- Understanding TGF-β's role in fibrosis is critical for developing effective treatments.
Purpose of the Study:
- To review recent advances in TGF-β signaling pathways.
- To elucidate the profibrotic mechanisms driven by TGF-β.
- To identify potential therapeutic targets within TGF-β signaling.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of signaling pathways involved in TGF-β-mediated fibrosis.
- Discussion of disease-specific alterations in TGF-β downstream components.
Main Results:
- TGF-β plays a significant profibrotic role.
- Mechanisms of ligand activation and downstream signaling pathways (Erk1/2 MAPK, PI3K/FAK, Endoglin/Smad1) contribute to fibrosis.
- Alterations in TGF-β signaling components are disease-specific.
Conclusions:
- TGF-β signaling is a central mediator of fibrosis.
- Detailed understanding of TGF-β pathways provides novel therapeutic avenues.
- Exploiting disease-specific pathway alterations holds promise for future interventions.
More Related Videos
06:02Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
Published on: June 10, 2016
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
TGF - β Signaling Pathway
Introduction to Fibroblasts
Chronic Inflammation: Introduction
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Intracellular Signaling Affects Focal Adhesions
Some...
Cirrhosis II: Pathophysiology